In the present case, immunoreactivity of p53 in tumor cells was different among SCCs, suggesting that these cancers were polyclonal, although distinct genetic abnormalities including loss of heterogeneity, gene mutations, and influence of oncogenic viral infection may be necessary to definitely determine polyclonality. The gene discussed is TP53; the disease is cancer.